A Study to Learn How Elinzanetant Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Kidneys That do Not Work as Well as They Should Compared to Participants Whose Kidneys Work Normally

Clinical trial NCT05071729 · COMPLETED

Trial details

NCT number: NCT05071729
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Start date: 2021-10-14
Primary completion: 2022-10-19
Enrollment: 31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.